Evidence map›Paper›PMID 33249517›Full record

SynthesisClinical research in cardiology : official journal of the German Cardiac Society2021

Thirty-day incidence of stroke after transfemoral transcatheter aortic valve implantation: meta-analysis and mixt-treatment comparison of self-expandable versus balloon-expandable valve prostheses.

Philipp C Seppelt, Silvia Mas-Peiro, Roberta De Rosa, Zisis Dimitriasis, Andreas M Zeiher, Mariuca Vasa-Nicotera

Open access · hybridAbstract readComparative StudySystematic ReviewNetwork Meta-Analysis
In one paragraph

Synthesis in Clinical research in cardiology : official journal of the German Cardiac Society, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. [Advances in stroke after transcatheter aortic valve replacement].Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences · 2025
    Review
  6. Cerebrovascular events after transcatheter aortic valve implantation.EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Philipp C SeppeltDivision of Cardiology, Department of Medicine III, University Hospital, Goethe University Frankfurt, Frankfurt am Main, Germany. Philipp.Seppelt@kgu.de.ORCID http://orcid.org/0000-0003-4743-6920
Silvia Mas-PeiroDivision of Cardiology, Department of Medicine III, University Hospital, Goethe University Frankfurt, Frankfurt am Main, Germany.
Roberta De RosaDivision of Cardiology, Department of Medicine III, University Hospital, Goethe University Frankfurt, Frankfurt am Main, Germany.
Zisis DimitriasisDivision of Cardiology, Department of Medicine III, University Hospital, Goethe University Frankfurt, Frankfurt am Main, Germany.
Andreas M ZeiherDivision of Cardiology, Department of Medicine III, University Hospital, Goethe University Frankfurt, Frankfurt am Main, Germany.
Mariuca Vasa-NicoteraDivision of Cardiology, Department of Medicine III, University Hospital, Goethe University Frankfurt, Frankfurt am Main, Germany.
Goethe University Frankfurt · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsStroke is a major complication after transcatheter aortic valve implantation (TAVI). Although multifactorial, it remains unknown whether the valve deployment system itself has an impact on the incidence of early stroke. We performed a meta- and network analysis to investigate the 30-day stroke incidence of self-expandable (SEV) and balloon-expandable (BEV) valves after transfemoral TAVI. METHODS AND

resultsOverall, 2723 articles were searched directly comparing the performance of SEV and BEV after transfemoral TAVI, from which 9 were included (3086 patients). Random effects models were used for meta- and network meta-analysis based on a frequentist framework. Thirty-day incidence of stroke was 1.8% in SEV and 3.1% in BEV (risk ratio of 0.62, 95% confidence interval (CI) 0.49-0.80, p = 0.004). Treatment ranking based on network analysis (P-score) revealed CoreValve with the best performance for 30-day stroke incidence (75.2%), whereas SAPIEN had the worst (19.0%). However, network analysis showed no inferiority of SAPIEN compared with CoreValve (odds ratio 2.24, 95% CI 0.70-7.2).

conclusionOur analysis indicates higher 30-day stroke incidence after transfemoral TAVI with BEV compared to SEV. We could not find evidence for superiority of a specific valve system. More randomized controlled trials with head-to-head comparison of SEV and BEV are needed to address this open question.

Indexed as

Aortic Valve StenosisHeart Valve ProsthesisHumansIncidencePostoperative ComplicationsProsthesis DesignRandomized Controlled Trials as TopicStrokeTranscatheter Aortic Valve ReplacementAortic stenosisBalloon-expandable TAVISelf-expandable TAVIStroke

Identifiers

PMID33249517
PMCPMC8099765
OpenAlexW3109540123

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.